ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,002Medicare Part D Prescriptions Filled, Including Refills

Rank: 398 out of 1383

$474K Total Retail Price of All Prescriptions

Rank: 388 out of 1383

379 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 7,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 477 439 1 2
LEVOTHYROXINE SODIUM 375 341 2 4
AMLODIPINE BESYLATE 339 320 3 6
LISINOPRIL 273 231 4 3
METOPROLOL TARTRATE 247 203 5 9
PRAVASTATIN SODIUM 229 199 6 14
FUROSEMIDE 218 185 7 7
POTASSIUM CHLORIDE 206 186 8 12
LOSARTAN POTASSIUM 191 176 9 23
OMEPRAZOLE 153 149 10 5
METFORMIN HCL 149 127 11 8
CITALOPRAM HBR 148 115 12 15
CLONIDINE HCL 143 115 13 44
ATORVASTATIN CALCIUM 141 136 14 18
AMLODIPINE BESYLATE-BENAZEPRIL 122 109 15 68
WARFARIN SODIUM 115 99 16 13
GABAPENTIN 112 97 17 11
ATENOLOL 107 104 18 16
HYDROCHLOROTHIAZIDE 101 89 19 10
GLIMEPIRIDE 100 98 20 31
METOPROLOL SUCCINATE 95 85 21 29
FLUTICASONE PROPIONATE 90 82 22 39
PANTOPRAZOLE SODIUM 88 83 23 32
BUSPIRONE HCL 84 73 24 109
LOSARTAN-HYDROCHLOROTHIAZIDE 84 80 24 60
PAROXETINE HCL 80 67 26 55
TAMSULOSIN HCL 77 68 27 30
MIRTAZAPINE 75 62 28 51
ALENDRONATE SODIUM 74 65 29 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 72 30 27
ISOSORBIDE MONONITRATE ER 70 69 31 66
NEXIUM 68 43 32 26
LOVASTATIN 67 58 33 22
FENOFIBRATE 62 62 34 65
ALLOPURINOL 62 46 34 33
LYRICA 61 47 36 72
CARVEDILOL 57 52 37 24
CLOPIDOGREL 57 47 37 28
CIPROFLOXACIN HCL 57 51 37 54
GLYBURIDE 57 49 R 37 46
MELOXICAM 57 55 37 20
ZETIA 55 32 42 101
SERTRALINE HCL 55 54 42 21
TRAZODONE HCL 54 47 44 36
DONEPEZIL HCL 53 53 45 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.